MASH

Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH).

movie clapper film premiere production

Biotech

Etiome emerges with $50M from Flagship, plans to preempt disease

The company combines multiomics data, AI and electronic health records to “build a molecular and cellular journey of disease."

Darren Incorvaia Apr 24, 2025 6:00am

Gloved hands putting together a liver out of puzzle pieces

Researchers ID potential MASH target by disrupting mouse gene

Mar 13, 2025 1:52pm

gold arrow pointing upward forward

Lilly inks $50M deal for biotech's FXR program

Feb 26, 2025 5:35am

Layoffs

Inventiva lays off 50% of staff to go all-in on MASH drug

Feb 11, 2025 7:30am

Three blocks displaying from left to right a person a handshake and another person

Lilly inks AdvanCell, OliX deals to expand in radiopharma, MASH

Feb 10, 2025 9:40am

gold arrow pointing upward forward

Akero's stock doubles as midphase MASH trial hits the mark

Jan 27, 2025 8:31am